Role of fasting plasma glucose, glycated haemoglobin and homeostatic model assessment in the detection of glucose intolerance in adult hypopituitary patients during growth hormone replacement therapy.
AIMS: This study was designed to determine the sensitivity and specificity of conventional criteria for diagnosis of impaired glucose tolerance (IGT) in a high-risk population of GH-treated GH deficient (GHD) adults. METHODS: 33 hypopituitary GHD patients with HbA(1c) >5.1% and 13 gender- and...
Päätekijät: | Colson, A, Walker, D, Besser, G, Grossman, AB, Chew, S, Jenkins, P, Drake, WM, Monson, J |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
2008
|
Samankaltaisia teoksia
-
Unmasking of central hypothyroidism following growth hormone replacement in adult hypopituitary patients.
Tekijä: Agha, A, et al.
Julkaistu: (2007) -
Safety of GH replacement in hypopituitary patients with nonirradiated pituitary and peripituitary tumours.
Tekijä: Chung, T, et al.
Julkaistu: (2008) -
Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Tekijä: Drake, WM, et al.
Julkaistu: (1998) -
Growth hormone replacement does not increase serum prostate-specific antigen in hypopituitary men over 50 years.
Tekijä: le Roux, C, et al.
Julkaistu: (2002) -
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy.
Tekijä: Frajese, G, et al.
Julkaistu: (2001)